MILESTONE PHARMACEUTICALS USA, INC. — Federal Contracts, Awards & Government Contractor Profile

About MILESTONE PHARMACEUTICALS USA, INC.

Milestone Pharmaceuticals is a patient-centric, commercial-stage biopharmaceutical company focused on developing treatments for acute episodes of paroxysmal supraventricular tachycardia (PSVT) and atrial fibrillation with rapid ventricular rate (AFib-RVR) that can be self-administered outside of healthcare settings. Their product, CARDAMYST™ (etripamil) nasal spray, is FDA approved for the conversion of acute symptomatic episodes of PSVT to sinus rhythm in adults.

Development of treatments for self-administration outside the emergency department or healthcare settingClinical investigation of etripamil, a novel calcium channel blocker, for acute self-treatment of patients with rapid heart rates associated with AFibFDA-approved product for the conversion of acute symptomatic episodes of PSVT to sinus rhythm in adults

Is this your company?

Claim MILESTONE PHARMACEUTICALS USA, INC. to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.

Claim MILESTONE PHARMACEUTICALS USA, INC. & see your matches

Free to claim. Takes about a minute.

Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.